Advanced BioHealing to Discuss Disruptive Innovation at BIOMEDevice Executive Forum

Panelists to discuss how convergent medical technology is redefining the life science sector

Westport, Conn. – April 19, 2010 – Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that Senior Vice President Dean Tozer will participate on a panel at the BIOMEDevice Executive Forum to be held April 21 – 22, 2010, at the Boston Convention & Exhibition Center in Boston, Mass.

Mr. Tozer will take part in a keynote panel discussion titled, “Disruptive Innovation” on Wednesday, April 21, 2010, at 9:45 a.m. EST. The panel will examine how convergent medical technology is redefining the life science sector through improved medical outcomes and decreased healthcare costs.

The BIOMEDevice Executive Forum will focus on convergence and cross-sector collaborations among biotechnology, medical device, IVD, and pharmaceutical companies. The Forum's scope will move beyond the FDA's definition of a combination product to address the paradigm shift in the life sciences.

For more information and to register for the meeting, please visit http://www.devicelink.com/expo/bioforum10/.

About Advanced BioHealing, Inc.
Advanced BioHealing develops and commercializes living cell therapies that repair damaged human tissue and enable the body to heal itself. A privately held company with more than 250 employees, Advanced BioHealing maintains its corporate office in Westport, Conn., a 70,000 sq. ft. manufacturing facility in La Jolla, Calif., and a research facility in Nashville, Tenn. To meet Advanced BioHealing’s executives and learn more about the Company, please visit the Company’s web site at www.ABH.com.

Media Contacts:

• Lindsey Hart
  • Advanced BioHealing
  • lhart@abh.com
  • Direct: (773) 697-3838
  • Cell: (206) 335-0114
• Mike Lizun
  • Gregory FCA
  • Mike@GregoryFCA.com
  • Direct: (610) 642-1435
  • Cell: (215) 313-0441